tiprankstipranks
SIGA Technologies Inc (SIGA)
NASDAQ:SIGA
US Market
Want to see SIGA full AI Analyst Report?

SIGA Technologies (SIGA) Price & Analysis

494 Followers

SIGA Stock Chart & Stats

$3.11
$0.04(1.29%)
At close: 4:00 PM EDT
$3.11
$0.04(1.29%)

Bulls Say, Bears Say

Bulls Say
Strong Balance SheetZero reported debt and a ~$118M cash balance give SIGA financial flexibility to fund manufacturing, R&D and program development without immediate external financing. Over the next 2–6 months this reduces solvency risk, supports bridge financing for lumpy orders and enables strategic execution.
Proven Government Contract ExecutionA long track record of fulfilling U.S. biodefense contracts (completion of 19C and deliveries since 2018) evidences operational reliability and established government relationships. This durable capability increases the likelihood of future awards and repeat procurements over multi‑year cycles.
International Expansion & PartnershipsNew licensing with Hikma and recent international deliveries broaden GEO exposure beyond the U.S., diversifying demand sources. Over months this structural expansion can reduce single‑market concentration, smooth revenue timing and create additional procurement channels for TPOXX.
Bears Say
Revenue Concentration / VariabilityA business model dominated by episodic government orders produces extreme quarter‑to‑quarter swings in revenue and utilization. This structural lumpy demand complicates forecasting, capacity planning and steady margin generation, raising execution risk over a 2–6 month horizon.
TTM Cash Flow And Margin DeteriorationSharp TTM declines in revenue and gross margin with materially negative operating and free cash flow represent a reversal from prior positive cash generation. If this trend persists, it could erode the cash runway, force operational cuts or require external funding, limiting strategic optionality.
Procurement Timing & Award UncertaintyOrganizational shifts within HHS and transfer of procurement responsibility have slowed the RFP/award timeline. Given SIGA's reliance on large government procurements, delays create persistent revenue visibility gaps and could prolong periods of lower deliveries and cash inflows.

SIGA Technologies News

SIGA FAQ

What was SIGA Technologies Inc’s price range in the past 12 months?
SIGA Technologies Inc lowest stock price was $2.83 and its highest was $9.45 in the past 12 months.
    What is SIGA Technologies Inc’s market cap?
    SIGA Technologies Inc’s market cap is $218.42M.
      When is SIGA Technologies Inc’s upcoming earnings report date?
      SIGA Technologies Inc’s upcoming earnings report date is Nov 05, 2026 which is in 73 days.
        How were SIGA Technologies Inc’s earnings last quarter?
        SIGA Technologies Inc released its earnings results on Aug 06, 2026. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
          Is SIGA Technologies Inc overvalued?
          According to Wall Street analysts SIGA Technologies Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does SIGA Technologies Inc pay dividends?
            SIGA Technologies Inc pays a Notavailable dividend of $0.6 which represents an annual dividend yield of N/A. See more information on SIGA Technologies Inc dividends here
              What is SIGA Technologies Inc’s EPS estimate?
              SIGA Technologies Inc’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does SIGA Technologies Inc have?
              SIGA Technologies Inc has 71,849,720 shares outstanding.
                What happened to SIGA Technologies Inc’s price movement after its last earnings report?
                SIGA Technologies Inc reported an EPS of $0.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.244%.
                  Which hedge fund is a major shareholder of SIGA Technologies Inc?
                  Currently, no hedge funds are holding shares in SIGA
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    SIGA Technologies Inc

                    SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.

                    SIGA Technologies (SIGA) Earnings & Revenues

                    SIGA Earnings Call

                    Q2 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call conveyed a predominantly positive operational and financial update driven by a strong Q2: profitable quarter, meaningful product deliveries (including completion of the 19C contract), an improving pipeline trajectory, expanding international partnerships (Hikma for MENA) and a solid balance sheet with $118M cash and no debt. Offsetting these positives are persistent execution risks tied to the timing of a new U.S. multiyear procurement award, quarter-to-quarter revenue volatility due to lumpy government orders, and the inherent complexity of international procurements. Overall, the company appears well-positioned but remains exposed to timing risks in government contracting.View all SIGA earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Emergent Biosolutions
                    Organogenesis Holdings
                    Aquestive Therapeutics

                    Ownership Overview

                    1.74%12.29%12.27%62.24%
                    12.27% Other Institutional Investors
                    62.24% Public Companies and
                    Individual Investors
                    Popular Stocks